SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $18,000 | +12.5% | 94 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $16,000 | +45.5% | 94 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | 0.0% | 94 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | +37.5% | 94 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | +14.3% | 94 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | 0.0% | 94 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $7,000 | -36.4% | 94 | -50.3% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | -26.7% | 189 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $15,000 | +15.4% | 189 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $13,000 | +30.0% | 189 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | 0.0% | 189 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,000 | – | 189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
| Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
| Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
| Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
| EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
| Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
| Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
| CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
| JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |